| Biological Sciences | Lifetime | 17 | FR 2 | 100.00 |
| Medical and Health Sciences | Lifetime | 489 | FR 6 | 99.98 |
| Biological Sciences | 2021-2025 | 16 | FR 1 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 87 | FR 1 | 99.98 |
| Molecular Biology | Lifetime | 12 | FR 1 | 99.99 |
| Epidemiology | Lifetime | 30 | FR 1 | 99.95 |
| Immunology | Lifetime | 25 | FR 1 | 99.95 |
| Oncology | Lifetime | 40 | FR 3 | 99.93 |
| Cancer Research | Lifetime | 173 | FR 5 | 99.05 |
| Cell Biology | Lifetime | 238 | FR 5 | 98.87 |
| Pulmonary and Respiratory Medicine | Lifetime | 652 | FR 36 | 99.04 |
| Physiology | Lifetime | 86 | FR 6 | 97.55 |
| Aging | Lifetime | 108 | FR 3 | 94.38 |
| Biotechnology | Lifetime | 434 | FR 21 | 93.22 |
| Virology | Lifetime | 566 | FR 32 | 78.19 |
| Immunology | 2021-2025 | 4 | FR 1 | 99.89 |
| Molecular Biology | 2021-2025 | 53 | FR 2 | 99.79 |
| Oncology | 2021-2025 | 23 | FR 3 | 99.87 |
| Epidemiology | 2021-2025 | 103 | FR 2 | 99.36 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 97 | FR 10 | 99.47 |
| Medical Physiology | 2021-2025 | 84 | FR 3 | 98.93 |
| Psychiatry and Mental health | 2021-2025 | 157 | FR 4 | 97.06 |
| Cancer Research | 2021-2025 | 112 | FR 3 | 94.83 |
| Cell Biology | 2021-2025 | 103 | FR 7 | 91.48 |
| Biological Psychiatry | 2021-2025 | 41 | FR 1 | 87.16 |
| Neuropsychology and Physiological Psychology | 2021-2025 | 81 | FR 2 | 77.09 |
| Mitochondrial Function and Pathology | Lifetime | 1 | FR 1 | 99.99 |
| Autophagy in Disease and Therapy | Lifetime | 1 | FR 1 | 100.00 |
| Cell death mechanisms and regulation | Lifetime | 1 | FR 1 | 100.00 |
| ATP Synthase and ATPases Research | Lifetime | 1 | FR 1 | 99.90 |
| Ferroptosis and cancer prognosis | Lifetime | 2 | FR 1 | 99.93 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 7 | FR 1 | 99.98 |
| Immunotherapy and Immune Responses | Lifetime | 11 | FR 2 | 99.97 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 6 | FR 1 | 99.90 |
| Phagocytosis and Immune Regulation | Lifetime | 2 | FR 1 | 99.97 |
| Cancer Research and Treatments | Lifetime | 17 | FR 1 | 99.83 |
| Cancer-related Molecular Pathways | Lifetime | 21 | FR 1 | 99.87 |
| Immune Cell Function and Interaction | Lifetime | 48 | FR 3 | 99.92 |
| RNA Interference and Gene Delivery | Lifetime | 47 | FR 2 | 99.76 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 64 | FR 4 | 99.72 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 8 | FR 1 | 99.43 |
| Immune cells in cancer | Lifetime | 29 | FR 1 | 99.74 |
| Adenosine and Purinergic Signaling | Lifetime | 22 | FR 1 | 99.34 |
| CAR-T cell therapy research | Lifetime | 55 | FR 3 | 99.73 |
| Cannabis and Cannabinoid Research | Lifetime | 23 | FR 2 | 99.56 |
| interferon and immune responses | Lifetime | 47 | FR 3 | 99.59 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 16 | FR 1 | 99.36 |
| Calcium signaling and nucleotide metabolism | Lifetime | 17 | FR 1 | 99.22 |
| RNA modifications and cancer | Lifetime | 287 | FR 5 | 99.31 |
| Epigenetics and DNA Methylation | Lifetime | 332 | FR 6 | 99.07 |
| Gut microbiota and health | Lifetime | 264 | FR 15 | 99.07 |
| Cancer, Lipids, and Metabolism | Lifetime | 222 | FR 6 | 99.06 |
| Immune Response and Inflammation | Lifetime | 339 | FR 7 | 99.11 |
| Genetics, Aging, and Longevity in Model Organisms | Lifetime | 88 | FR 1 | 98.63 |
| DNA Repair Mechanisms | Lifetime | 287 | FR 6 | 98.54 |
| T-cell and B-cell Immunology | Lifetime | 487 | FR 25 | 99.07 |
| Polyamine Metabolism and Applications | Lifetime | 125 | FR 2 | 97.87 |
| PARP inhibition in cancer therapy | Lifetime | 131 | FR 6 | 98.04 |
| Inflammasome and immune disorders | Lifetime | 179 | FR 14 | 98.05 |
| Heat shock proteins research | Lifetime | 152 | FR 3 | 97.91 |
| Microtubule and mitosis dynamics | Lifetime | 289 | FR 13 | 97.82 |
| RNA regulation and disease | Lifetime | 277 | FR 7 | 97.36 |
| Ubiquitin and proteasome pathways | Lifetime | 675 | FR 22 | 97.24 |
| NF-κB Signaling Pathways | Lifetime | 318 | FR 9 | 96.99 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 395 | FR 11 | 96.92 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 624 | FR 14 | 96.92 |
| Dietary Effects on Health | Lifetime | 181 | FR 7 | 96.29 |
| Trace Elements in Health | Lifetime | 613 | FR 22 | 96.73 |
| Tryptophan and brain disorders | Lifetime | 945 | FR 18 | 96.13 |
| Histone Deacetylase Inhibitors Research | Lifetime | 921 | FR 29 | 93.00 |
| Telomeres, Telomerase, and Senescence | Lifetime | 489 | FR 18 | 92.94 |
| Cancer Mechanisms and Therapy | Lifetime | 937 | FR 37 | 91.98 |
| Nuclear Receptors and Signaling | Lifetime | 927 | FR 39 | 89.47 |
| Immune responses and vaccinations | Lifetime | 605 | FR 26 | 86.05 |
| Calpain Protease Function and Regulation | Lifetime | 583 | FR 33 | 81.16 |
| Immunotherapy and Immune Responses | 2021-2025 | 2 | FR 1 | 99.93 |
| Autophagy in Disease and Therapy | 2021-2025 | 1 | FR 1 | 99.94 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 11 | FR 1 | 99.94 |
| Ferroptosis and cancer prognosis | 2021-2025 | 3 | FR 1 | 99.88 |
| Immune Cell Function and Interaction | 2021-2025 | 5 | FR 1 | 99.70 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 1 | FR 1 | 99.84 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 3 | FR 1 | 99.46 |
| RNA modifications and cancer | 2021-2025 | 32 | FR 1 | 99.62 |
| Phagocytosis and Immune Regulation | 2021-2025 | 3 | FR 1 | 98.42 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 17 | FR 2 | 99.47 |
| Tryptophan and brain disorders | 2021-2025 | 73 | FR 2 | 97.79 |
| Gut microbiota and health | 2021-2025 | 226 | FR 5 | 98.02 |
| T-cell and B-cell Immunology | 2021-2025 | 88 | FR 4 | 96.69 |
| Dietary Effects on Health | 2021-2025 | 40 | FR 1 | 94.99 |
| Calcium signaling and nucleotide metabolism | 2021-2025 | 13 | FR 1 | 94.83 |
| CAR-T cell therapy research | 2021-2025 | 452 | FR 24 | 97.20 |
| Cancer Cells and Metastasis | 2021-2025 | 167 | FR 5 | 94.10 |
| Adipose Tissue and Metabolism | 2021-2025 | 249 | FR 3 | 94.31 |
| Telomeres, Telomerase, and Senescence | 2021-2025 | 42 | FR 3 | 94.44 |
| Epigenetics and DNA Methylation | 2021-2025 | 529 | FR 6 | 93.26 |
| Genetics, Aging, and Longevity in Model Organisms | 2021-2025 | 86 | FR 1 | 93.43 |
| PARP inhibition in cancer therapy | 2021-2025 | 139 | FR 11 | 95.14 |
| Cannabis and Cannabinoid Research | 2021-2025 | 178 | FR 3 | 94.44 |
| Diet and metabolism studies | 2021-2025 | 785 | FR 5 | 93.35 |
| Immune cells in cancer | 2021-2025 | 650 | FR 7 | 90.60 |
| DNA Repair Mechanisms | 2021-2025 | 246 | FR 10 | 90.58 |
| interferon and immune responses | 2021-2025 | 313 | FR 8 | 89.61 |
| Cancer Research and Treatments | 2021-2025 | 258 | FR 3 | 89.56 |
| Polyamine Metabolism and Applications | 2021-2025 | 59 | FR 1 | 90.10 |
| Circular RNAs in diseases | 2021-2025 | 541 | FR 2 | 90.14 |
| Neuropeptides and Animal Physiology | 2021-2025 | 190 | FR 2 | 88.29 |
| Cell death mechanisms and regulation | 2021-2025 | 73 | FR 5 | 87.36 |
| Adenosine and Purinergic Signaling | 2021-2025 | 176 | FR 6 | 85.44 |
| Trace Elements in Health | 2021-2025 | 349 | FR 10 | 85.78 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 408 | FR 5 | 83.82 |
| Heat shock proteins research | 2021-2025 | 145 | FR 2 | 82.17 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 317 | FR 13 | 75.76 |
| Pharmacological Receptor Mechanisms and Effects | 2021-2025 | 224 | FR 8 | 71.59 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 376 | FR 8 | 71.40 |
| Aging and Gerontology Research | 2021-2025 | 983 | FR 9 | 60.95 |